|
|
||||||||
From the Laboratories of the International Health Division of the Rockefeller Foundation, New York
Abstract
Immune serum administered intranasally was much more effective in preventing pulmonary infection with influenza A virus in mice than a proportional amount of immune serum injected intraabdominally. The protective action of the immune serum intranasally introduced was demonstrated for at least 48 hours following its administration.
Although mice receiving 30 MLD of virus were protected when immune serum was given intranasally within 6 hours, consistent protection against death could not be achieved if the instillation of the serum was delayed for 24 hours after inoculation of the virus.
The manner of action and possible use of intranasally administered immune serum have been briefly discussed.
This article has been cited by other articles:
![]() |
E. H. LENNETTE RECENT ADVANCES IN VIRUSES: A BRIEF SURVEY OF RECENT WORK ON VIRUSES AND VIRUS DISEASES Science, November 12, 1943; 98(2550): 415 - 423. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |